VINCRISTINE SULFATE INJECTION 1 MG — DIN 02143305
VINCRISTINE SULFATE : 1 MG · TEVA CANADA LIMITED · SOLUTION · wholesale supply in Canada
Health Canada status: MARKETED
What is VINCRISTINE SULFATE INJECTION?
VINCRISTINE SULFATE INJECTION 1 MG contains VINCRISTINE SULFATE : 1 MG. It is listed in the Health Canada Drug Product Database under DIN 02143305, held by TEVA CANADA LIMITED, supplied as SOLUTION for INTRAVENOUS administration. Health Canada currently lists it as marketed, status dated 12-Apr-2014. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is VINCRISTINE SULFATE INJECTION used for?
Acute leukemia, Hodgkin's disease, lymphomas, various sarcomas, breast cancer, lung cancer, Wilms' tumor, and refractory idiopathic thrombocytopenic purpura.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
How much does Vincristine cost around the world?
Vincristine is listed on 5 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Morocco publishes a PPV (public price); Saudi Arabia publishes a public. Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| Morocco | PPV (public price) | 4 | 7 | MAD███.██ |
| Saudi Arabia | public | 3 | 6 | SAR███.██ |
| United Kingdom | hospital | 4 | 4 | GBP███.██ |
| Australia | ex-manufacturer | 1 | 2 | AUD███.██ |
| South Africa | single exit price | 2 | 2 | ZAR███.██ |
21 pack listings across 14 brand entries and 5 price bases, refreshed 08 Sep 2026. Ranges span every Vincristine pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Vincristine in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
6 holders have a Canadian DIN containing Vincristine, across 7 DINs, of which 2 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| PFIZER CANADA ULC | 1 | 1 | VINCRISTINE SULFATE INJECTION USP | Sourceable in Canada |
| TEVA CANADA LIMITED | 1 | 1 | VINCRISTINE SULFATE INJECTION | Sourceable in Canada |
| DAVID BULL LABORATORIES (PTY) LTD. | 2 | 0 | VINCRISTINE SULFATE INJ 1MG/ML USP, VINCRISTINE SULFATE INJ 5MG/VIAL USP | No marketed DIN |
| ACCORD HEALTHCARE INC | 1 | 0 | VINCRISTINE SULFATE INJECTION | No marketed DIN |
| ELI LILLY CANADA INC | 1 | 0 | ONCOVIN SOLUTION 1MG/ML | No marketed DIN |
| UMAN PHARMA INC | 1 | 0 | VINCRISTINE SULFATE INJECTION USP | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 1 MG |
|---|---|
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
| Pack configuration (monograph) | Pharmacy Bulk Vials containing 1 mg/mL in 5 mL sterile, unpreserved solution. |
| Storage | Store under refrigeration (2° to 8°C). Do not freeze. Protect from light. |
| Shipping class | Cold chain — validated shipper with temperature monitoring |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Cold chain. This product is stored refrigerated. Nexara ships it on a validated cold chain with temperature monitoring; a delivery address that cannot receive and store it at 2–8 °C on arrival must be flagged before the order is placed.
Substance and classification
| Active substance | Vincristine |
|---|---|
| ATC code | L01CA02 |
| AHFS class | 28:08.04.92 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02143305 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2143305 |
| Brand name | VINCRISTINE SULFATE INJECTION |
| Generic / active ingredient | VINCRISTINE SULFATE : 1 MG |
| Market authorization holder | TEVA CANADA LIMITED |
| Health Canada schedule | Prescription |
| ATC code | L01CA02 |
| ATC anatomical main group | L — Antineoplastic and immunomodulating agents |
| ATC therapeutic subgroup | L01CA |
| Current status | MARKETED |
| Status date | 12-Apr-2014 |
| Original market date | 1997-01-21 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
How is it administered?
Intravenous use only at weekly intervals. Usual dose: 2 mg/m2 for children, 1.4 mg/m2 for adults. For children ≤10 kg, start at 0.05 mg/kg. Dilute in flexible plastic container.
Included because it drives pack selection and wastage. Consult the monograph.
Contraindications
Patients with the demyelinating form of Charcot-Marie-Tooth Syndrome.
Warnings and precautions
FOR INTRAVENOUS USE ONLY; FATAL IF GIVEN BY OTHER ROUTES. Intrathecal administration usually results in death. Avoid extravasation (tissue irritation). Monitor blood counts weekly.
Is Vincristine in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Resolved — reported by TEVA CANADA LIMITED, last seen 09 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
2 of 7 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| VINCRISTINE SULFATE INJECTION USP | 1 MG | SOLUTION | PFIZER CANADA ULC | MARKETED | 02183013 |
| ONCOVIN SOLUTION 1MG/ML | 1 MG | LIQUID | ELI LILLY CANADA INC | CANCELLED POST MARKET | 00611182 |
| VINCRISTINE SULFATE INJ 1MG/ML USP | 1 MG | LIQUID | DAVID BULL LABORATORIES (PTY) LTD. | CANCELLED POST MARKET | 00726575 |
| VINCRISTINE SULFATE INJ 5MG/VIAL USP | 5 MG | POWDER FOR SOLUTION | DAVID BULL LABORATORIES (PTY) LTD. | CANCELLED POST MARKET | 00690317 |
| VINCRISTINE SULFATE INJECTION | 1 MG | SOLUTION | ACCORD HEALTHCARE INC | CANCELLED PRE MARKET | 02324148 |
| VINCRISTINE SULFATE INJECTION USP | 1 MG | SOLUTION | UMAN PHARMA INC | CANCELLED PRE MARKET | 02333198 |
2 · Same class — other molecules in ATC L01CA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Vinorelbine | AJ-VINORELBINE · NAVELBINE · VINORELBINE INJECTION · VINORELBINE INJECTION, USP · +2 more | 9 | 3 | Yes |
| Vincristine | ONCOVIN SOLUTION 1MG/ML · VINCRISTINE SULFATE INJ 1MG/ML USP · VINCRISTINE SULFATE INJ 5MG/VIAL USP · VINCRISTINE SULFATE INJECTION · +1 more | 7 | 2 | Yes |
| Vinblastine | VELBE 1MG/ML · VINBLASTINE SULFATE INJ 1MG/ML · VINBLASTINE SULFATE INJECTION · VINBLASTINE SULPHATE INJECTION | 5 | 2 | Yes |
| Vindesine | ELDISINE INJ 5MG/2ML | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC L01C
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| L01CD | Cabazitaxel · Docetaxel · Paclitaxel | 41 | 13 |
| L01CE | Irinotecan · Topotecan | 32 | 12 |
| L01CB | Etoposide · Teniposide | 14 | 3 |
| L01CX | Trabectedin | 1 | 1 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is VINCRISTINE SULFATE INJECTION called?
The same molecule, Vincristine, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| VINCRISTINE COOPER | Latin | Morocco |
| DBL Vincristine Sulfate | Latin | Australia |
| OKA-VINCRISTINE | Latin | Morocco |
| ONCOVIN | Latin | Morocco |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.